PROFORMANT Contact Us
Company Services Clients Resources Partners News Site Map
Our Clients
Experience
Pharmaceuticals
Biotechnology
Medical Devices
Diagnostics
Alliances
Specialties
Success Stories

Our Experience

Strategic Alliances

We have identified, analyzed, and structured strategic alliances for clients in all positions: acquirer and target; marketer and developer; and synergistic equals.

Representative engagements have addressed alliances between the companies given below. Our strategic diligence has enabled our clients to confidently pursue some of the alliances given, as well as to discontinue pursuit of others following our clarification of certain issues. Preserving confidentiality, we do not specify whether the companies given below were our clients during the diligence, nor is the client list given elsewhere on this site complete.

  • Abbott and an Emerging Diagnostics Company
  • Alexion and a Major Biopharmaceutical Company
  • Alkermes and a Major Biopharmaceutical Company
  • Alliance Pharmaceuticals and a Major Biopharmaceutical Company
  • Alpha Beta Technologies and a Major Biopharmaceutical Company
  • Alza and a Major Biopharmaceutical Company
  • Ampersand and a Specialty Surgical Products Company
  • Arrow and an Emerging Medical Device Company
  • AWS and a Major Medical Products Company
  • Biogen and an Emerging Biopharmaceutical Company
  • British Biotech and a Major Biopharmaceutical Company
  • BZL and a Major Biopharmaceutical Company
  • Cambridge Neuroscience and a Major Biopharmaceutical Company
  • Diacrin and a Major Biopharmaceutical Company
  • Diagnostic Technologies and a Major Diagnostics Company
  • Eli Lilly and an Expansion-stage Medical Device Company
  • Fresenius and an Expansion-stage Medical Device Company
  • GelTex and a Major Biopharmaceutical Company
  • Genentech and a Major Biopharmaceutical Company
  • Genovo and a Major Biopharmaceutical Company
  • Guilford Pharmaceuticals and a Major Biopharmaceutical Company
  • Johnson & Johnson and a Major Biopharmaceutical Company
  • Johnson & Johnson and an Emerging Medical Products Company
  • LifeScan and an Emerging Medical Device Company
  • Mallinckrodt Group and a Major Biopharmaceutical Company
  • Mallinckrodt Medical and a Major Biopharmaceutical Company
  • MC Catheter and a Major Medical Products Company
  • Millennium Biologics and an Emerging Biopharmaceutical Company
  • Millennium Pharmaceuticals and an Emerging Biopharmaceutical Company
  • MIRA and a Specialty Surgical Products Company
  • Misonix and a Specialty Medical Products Company
  • MMS and a Major Medical Products Company
  • Neurocrine and an Emerging Biopharmaceutical Company
  • NPS Pharmaceuticals and a Major Biopharmaceutical Company
  • Pharmacia and a Major Biopharmaceutical Company
  • Sanofi and an Emerging Biopharmaceutical Company
  • Schering-Plough and an Emerging Biopharmaceutical Company
  • Scios-Nova and a Major Biopharmaceutical Company
  • Searle and a Major Pharmaceutical Company
  • T-Cell Sciences and a Major Biopharmaceutical Company
  • ViaCirq and a Major Biopharmaceutical Company

PROFORMANT publishes its Pulmonary Biopharmaceutical Outlook. more


Download Brochure
PROFORMANT Privacy Policy Disclaimer